• FirefoxInstall the new Firefox »
  •  Dow Up0.21% Nasdaq Up0.32%

    Infinity Pharmaceuticals, Inc. (INFI)

    -NasdaqGS
    16.51 Up 0.34(2.10%) 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 4,356   160,639   -   -  
    Cost of Revenue -   -   -   -  
    Gross Profit 4,356   160,639   -   -  
    Operating Expenses
    Research Development36,082  44,895  28,165  34,491  
    Selling General and Administrative7,382  8,042  7,057  6,804  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (39,108) 107,702   (35,222) (41,295)
    Income from Continuing Operations
    Total Other Income/Expenses Net(17)52  136  168  
    Earnings Before Interest And Taxes(39,125)107,754  (35,086)(41,127)
    Interest Expense1,034  4,538  2,938  1,139  
    Income Before Tax(40,159)103,216  (38,024)(42,266)
    Income Tax Expense183   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(40,342)103,216  (38,024)(42,266)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (40,342) 103,216   (38,024) (42,266)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (40,342) 103,216   (38,024) (42,266)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.